Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
tadalafil, Quantity: 20 mg
Cipla Australia Pty Ltd
Tadalafil
Tablet
Excipient Ingredients: microcrystalline cellulose; sodium lauryl sulfate; hyprolose; croscarmellose sodium; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; triacetin; iron oxide yellow
Oral
8, 2, 4, 1
(S4) Prescription Only Medicine
CIPLA TADALAFIL is indicated for the treatment of: ? erectile dysfunction (ED) in adult males ? moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult males
Visual Identification: Yellow coloured, capsule shaped, biconvex film coated tablet with "T 20" debossed on one side and plain on other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-03-27